Filter
3240
Filtered Results: 3240
Text search:
blood
components
Featured
Recommendations
357
New Publications
1005
Language
Document type
No document type
1994
Guidelines
461
Studies & Reports
384
Manuals
185
Strategic & Response Plan
91
Training Material
57
Fact sheets
39
Situation Updates
15
Brochures
6
Infographics
4
Resource Platforms
3
Online Courses
1
Countries / Regions
India
242
Kenya
122
Global
115
Ethiopia
82
Nigeria
74
South Africa
73
Nepal
72
Sierra Leone
71
Tanzania
71
Liberia
69
Uganda
66
Zambia
55
Ghana
54
Malawi
52
Bangladesh
51
Rwanda
44
Western and Central Europe
44
Philippines
40
Myanmar / Burma
36
Latin America and the Carribbean
35
Africa
32
Namibia
29
Lesotho
26
South–East Asia Region
24
Zimbabwe
23
Cambodia
23
Asia
21
Ukraine
20
Syria
18
Congo, Democratic Republic of
16
Eswatini/ Swaziland
15
Senegal
14
Mozambique
14
Indonesia
14
Botswana
13
Guinea
12
Pakistan
12
Haiti
11
Eastern Europe and Central Asia
11
Cameroon
10
Eastern Europe
9
USA
8
West and Central Africa
8
East and Southern Africa
8
Russia
8
Yemen
8
Germany
7
Georgia
7
South Sudan
7
Western Pacific Region
6
Brazil
6
Tajikistan
5
Albania
5
Burkina Faso
5
Afghanistan
5
Middle East and North Africa
5
Thailand
4
Laos
4
Jordan
4
North America
4
Sri Lanka
4
Iraq
4
Benin
3
Peru
3
Saudi Arabia
3
United Kingdom
3
Southern Africa
3
Bolivia
3
Lebanon
3
Papua New Guinea
3
Moldova
3
Sudan
3
Somalia
3
North Macedonia
2
Colombia
2
Timor Leste/ East Timor
2
El Salvador
2
China
2
Kazakhstan
2
Iran
2
Kyrgyzstan
2
Burundi
2
Venezuela
2
Paraguay
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Vietnam
2
Central African Republic
2
Mali
2
Libya
2
Bhutan
2
Ecuador
2
Serbia
1
Turkey
1
Gambia
1
Chile
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
Guinea-Bissau
1
Lithuania
1
Turkmenistan
1
Japan
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Israel
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Chad
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1363
Clinical Guidelines
405
Public Health
235
Women & Child Health
190
Key Resources
114
Capacity Building
96
Pharmacy & Technologies
59
Toolboxes
HIV
278
Mental Health
156
TB
148
COVID-19
119
Caregiver
116
Rapid Response
105
NCDs
103
AMR
94
Ebola
91
NTDs
80
Pharmacy
75
Planetary Health
65
Conflict
58
Refugee
38
Global Health Education
34
Disability
31
Zika
27
Specific Hazards
23
Natural Hazards
20
Cholera
14
Social Ethics
10
Health Financing Toolbox
10
Polio
9
March 2021
This report presents the key findings of the NFHS-5 survey in Tripura, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and...
March 2021
This report presents the key findings of the NFHS-5 survey in Manipur, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and...
May 2021
This report presents the key findings of the NFHS-5 survey in Andhra Pradesh, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for Indi...
March 2021
This report presents the key findings of the NFHS-5 survey in Kerala, followed by detailed tables and an appendix on sampling errors. The 2019-21 National Family Health Survey (NFHS-5), the fifth in the NFHS series, provides information on population, health, and nutrition for India and ...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
1.1 Why this course is needed
The first few hours and days of a newborn baby’s life are a critical window for establishing breastfeeding and for providing mothers with the support they need to breastfeed successfully. Since 1991, the Baby-friendly Hospital Initiative (BFHI) has helped to motivate...
Available in English, French and Spanish
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
El presente documento reúne un conjunto de recomendaciones formuladas por la Organización Mundial de la Salud (OMS) y la Organización Panamericana de la Salud (OPS) para ayudar, a los profesionales encargados de los programas de control de vectores de Latinoamérica y el Caribe a nivel nacional, ...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Schistosomiasis is a neglected tropical disease of global medical and veterinary importance. As efforts to eliminate schistosomiasis as a public health problem and interrupt transmission gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridisation in s...
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
